trending Market Intelligence /marketintelligence/en/news-insights/trending/bCU4RqQCZEUTU67acTHLRQ2 content esgSubNav
In This List

Mylan launches generic version of EpiPen

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Mylan launches generic version of EpiPen

Mylan NV launched an authorized generic for its EpiPen Auto-Injector at $300 for a pack of two injections.

The generic product has the same drug formulation and device functionality as EpiPen and will reach retail pharmacies in the week of Dec. 19.